FBGRX
Price
$228.74
Change
-$8.02 (-3.39%)
Updated
Dec 18 closing price
GFAFX
Price
$74.18
Change
-$9.64 (-11.50%)
Updated
Dec 18 closing price
Ad is loading...

FBGRX vs GFAFX

Header iconFBGRX vs GFAFX Comparison
Open Charts FBGRX vs GFAFXBanner chart's image
Fidelity Blue Chip Growth
Price$228.74
Change-$8.02 (-3.39%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer F1
Price$74.18
Change-$9.64 (-11.50%)
VolumeN/A
CapitalizationN/A
FBGRX vs GFAFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBGRX vs. GFAFX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBGRX is a StrongBuy and GFAFX is a Buy.

FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 313B vs. FBGRX (72.7B). GFAFX pays higher dividends than FBGRX: GFAFX (0.45) vs FBGRX (0.00). FBGRX was incepted earlier than GFAFX: FBGRX (37 years) vs GFAFX (24 years). GFAFX is a more actively managed with annual turnover of: 31.00 vs. FBGRX (19.00). FBGRX has a lower initial minimum investment than GFAFX: FBGRX (0) vs GFAFX (250). FBGRX annual gain was more profitable for investors over the last year : 36.95 vs. GFAFX (19.09). FBGRX return over 5 years is better than : 121.00 vs. GFAFX (47.42).
FBGRXGFAFXFBGRX / GFAFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years24 years-
Gain YTD36.92118.858196%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets72.7B313B23%
Annual Yield % from dividends0.000.45-
Returns for 1 year36.9519.09194%
Returns for 3 years33.745.18652%
Returns for 5 years121.0047.42255%
Returns for 10 years245.4375.18326%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGL4.810.15
+3.22%
NGL Energy Partners LP
CSPI17.990.51
+2.92%
CSP
ADNT17.60-0.01
-0.06%
Adient plc
FWONA85.52-0.66
-0.77%
Liberty Media Corp
RLMD0.36-0.03
-6.97%
Relmada Therapeutics